Chronic neutrophilic leukemia associated with thrombocytosis and a CSF3R Q781* nonsense mutation.
暂无分享，去创建一个
[1] A. Tefferi,et al. Chronic neutrophilic leukemia: 2022 update on diagnosis, genomic landscape, prognosis, and management , 2022, American journal of hematology.
[2] D. DeAngelo,et al. A Novel CSF3R Activating Mutation Identified in a Patient with Chronic Neutrophilic Leukemia , 2021, Blood.
[3] B. Druker,et al. Mutant-SETBP1 activates transcription of Myc programs to accelerate CSF3R-driven myeloproliferative neoplasms , 2021, bioRxiv.
[4] Yan Chen,et al. CSF3R T618I, SETBP1 G870S, SRSF2 P95H, and ASXL1 Q780* tetramutation co-contribute to myeloblast transformation in a chronic neutrophilic leukemia , 2021, Annals of Hematology.
[5] J. Tyner,et al. What's different about atypical CML and chronic neutrophilic leukemia? , 2015, Hematology. American Society of Hematology. Education Program.
[6] J. Tyner,et al. CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia , 2013, Leukemia.
[7] Iannis Aifantis,et al. ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression. , 2012, Cancer cell.
[8] S. Kunishima,et al. [A case of chronic neutrophilic leukemia with abnormal karyotype]. , 1989, Rinsho byori. The Japanese journal of clinical pathology.